通过血检预测肺癌患者的治疗效果
|
By LabMedica International staff writers Posted on 10 Nov 2017 |
|
图片：cobas EGFR突变检验v2 CE-IVD能识别非小细胞肺癌(NSCLC)患者DNA里的表皮生长因子受体(EGFR)基因（图片蒙罗氏分子诊断公司惠赐）。
诊断肺癌的传统方法仅依靠肺活组织检查，它是一种创伤性手术，许多患者难以忍受。一项简易血检能用血样检测肿瘤DNA里的基因突变，且诊断速度更快，更多享受到救命药，从而让肺癌患者有了新选择。
2014年，肺癌是英国的第三大常见癌症，英国剑桥癌症研究所的最新统计数据显示，有46,400例肺癌新病例。这项新检验为靶向表皮生长因子受体(EGFR)异常的分子疗法严格把关，快速识别适于靶向疗法的患者，使他们避免化疗及其副作用。
英国NHS信托基金会下属的伯明翰大学医院(UH)将该检验引入其著名的癌症诊断实验室。新的化验服务让更多患者享受到救命的治疗，且副作用小于传统化疗，从而改善了患者的生活质量。该检验特异性强，结果可用来预测病人对治疗的反应，让医生能够快速制定个性化治疗方案，且方案符合英格兰NHS的目标——确保个性化治疗及医治每个诊断出癌症的人。
美国加利福尼亚州普莱森顿市罗氏分子诊断公司)的cobas EGFR突变检验v2 CE-IVD能识别非小细胞肺癌(NSCLC)患者DNA里的表皮生长因子受体(EGFR)基因，旨在辅助选出适于EGFR酪氨酸激酶抑制剂(TKI)疗法的NSCLC患者。这款创新性测定产品第一次用血浆作为除组织外的另一种样本类型，因而消除了分子检验的常见障碍，包括手术风险和是否可得到样本。该检验的结果清晰、实用，能为临床医师做出可信的治疗决策提供信息。
cobas EGFR突变检验v2 CE-IVD的报表中有一项新特征，称为半量化指标(SQI)。这个数值的设计目的是表示样本里突变的百分比。如果用该产品频繁检验EGFR突变，追踪SQI值并找出趋势，也许就能理解肿瘤的进展，而其它检验产品还不具备这一功能。
UHB的组织病理医师Phillipe Taniere博士说：“识别血样里的突变一直是个难题，因为样本里发现癌细胞的频率很低。然而，罗氏诊断公司的这项强大的新技术有可能取一份简单的血样就能发现肿瘤DNA里的EGFR突变。”
Related Links:
NHS信托基金会下属伯明翰大学医院
罗氏分子诊断公司
2014年，肺癌是英国的第三大常见癌症，英国剑桥癌症研究所的最新统计数据显示，有46,400例肺癌新病例。这项新检验为靶向表皮生长因子受体(EGFR)异常的分子疗法严格把关，快速识别适于靶向疗法的患者，使他们避免化疗及其副作用。
英国NHS信托基金会下属的伯明翰大学医院(UH)将该检验引入其著名的癌症诊断实验室。新的化验服务让更多患者享受到救命的治疗，且副作用小于传统化疗，从而改善了患者的生活质量。该检验特异性强，结果可用来预测病人对治疗的反应，让医生能够快速制定个性化治疗方案，且方案符合英格兰NHS的目标——确保个性化治疗及医治每个诊断出癌症的人。
美国加利福尼亚州普莱森顿市罗氏分子诊断公司)的cobas EGFR突变检验v2 CE-IVD能识别非小细胞肺癌(NSCLC)患者DNA里的表皮生长因子受体(EGFR)基因，旨在辅助选出适于EGFR酪氨酸激酶抑制剂(TKI)疗法的NSCLC患者。这款创新性测定产品第一次用血浆作为除组织外的另一种样本类型，因而消除了分子检验的常见障碍，包括手术风险和是否可得到样本。该检验的结果清晰、实用，能为临床医师做出可信的治疗决策提供信息。
cobas EGFR突变检验v2 CE-IVD的报表中有一项新特征，称为半量化指标(SQI)。这个数值的设计目的是表示样本里突变的百分比。如果用该产品频繁检验EGFR突变，追踪SQI值并找出趋势，也许就能理解肿瘤的进展，而其它检验产品还不具备这一功能。
UHB的组织病理医师Phillipe Taniere博士说：“识别血样里的突变一直是个难题，因为样本里发现癌细胞的频率很低。然而，罗氏诊断公司的这项强大的新技术有可能取一份简单的血样就能发现肿瘤DNA里的EGFR突变。”
Related Links:
NHS信托基金会下属伯明翰大学医院
罗氏分子诊断公司
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Gold Member
Collection and Transport System
PurSafe Plus®
Latest 临床化学 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more